Expand DCTH Menu
DCTH MENU

DCTH Latest Press Releases

-- April 23, 2026 --

Delcath Systems to Host First Quarter 2026 Earnings Call Business Wire 8:30 AM

-- April 6, 2026 --

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO-EURACAN Clinical Practice Guidelines for Uveal Melanoma Business Wire 8:30 AM

-- April 1, 2026 --

Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting Business Wire 8:30 AM

-- March 3, 2026 --

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology Business Wire 8:00 AM

-- February 26, 2026 --

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results Business Wire 8:00 AM

-- February 12, 2026 --

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call Business Wire 8:00 AM

-- January 27, 2026 --

Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference Business Wire 8:05 AM

-- January 21, 2026 --

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- January 9, 2026 --

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results Business Wire 8:05 AM

-- December 31, 2025 --

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma Business Wire 8:00 AM

-- December 3, 2025 --

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma Business Wire 4:01 PM
Market Data Delayed 15 Minutes